Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes

被引:22
|
作者
Vu, Dinh H. [1 ]
Nguyen, Duy A. [1 ]
Delattre, Isabelle K. [2 ]
Ho, Trong T. [1 ]
Do, Hong G. [3 ]
Pham, Hong N. [4 ]
Dao, Xuan C. [5 ]
Tran, Nhan T. [3 ]
Nguyen, Gia B. [5 ]
Van Bambeke, Francoise [2 ]
Tulkens, Paul M. [2 ]
Nguyen, Hoang A. [1 ]
机构
[1] Hanoi Univ Pharm, Natl Drug Informat & Adverse Drug React Monitorin, 13-15 Le Thanh Tong, Hanoi, Vietnam
[2] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium
[3] Bach Mai Hosp, Dept Pharm, Hanoi, Vietnam
[4] Bach Mai Hosp, Dept Microbiol, Hanoi, Vietnam
[5] Bach Mai Hosp, Intens Care Unit, Hanoi, Vietnam
关键词
Vancomycin; Continuous infusion; Loading dose; Maintenance dose; Critically ill; AUGMENTED RENAL CLEARANCE; INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-AUREUS; INTERMITTENT INFUSION; PHARMACODYNAMICS; INFECTIONS; SIZE;
D O I
10.1016/j.ijantimicag.2019.09.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Despite extensive clinical use, limited data are available on optimal loading and maintenance doses of vancomycin in critically ill patients. This study aimed to develop a rational approach for optimised dosage of vancomycin given in a continuous infusion in critically ill patients. Methods: Vancomycin pharmacokinetic (PK) data (total serum concentrations) were obtained from 55 intensive care unit (ICU) patients (Bach Mai Hospital, Hanoi, Vietnam) receiving a 20 mg/kg loading dose followed by continuous infusion stratified by creatinine clearance (CLCr). Population PK modelling and Monte Carlo simulations were performed using a nonlinear mixed-effects modelling (NONMEM) program for a target of 20-30 mg/L to optimise efficacy and minimise nephrotoxicity. Results: A two-compartment model with first-order elimination best fitted the PK data with central and peripheral volumes of distribution of 1.01 and 2.39 L/kg, respectively (allometric scaling to a 70 kg standard subject). The population total clearance of 3.63 L/h was only explained by renal function in the covariate and final model. The simulations showed that a 25-mg/kg loading dose infused over 90 minutes was optimal to reach the target range. The optimal maintenance dose for low renal function (CLCr < 45 mL/min) was 1000-1500 mg/day. For augmented renal clearance (CLCr > 130 mL/min) the dose should be up to 3500 mg/day or even 4500 mg/day to achieve adequate exposure. These simulated maintenance doses were larger than previously proposed for non-ICU patients. Conclusion: Large loading and maintenance doses of vancomycin are generally needed in critically ill patients. Because of high interindividual variability in vancomycin PK, drug monitoring may still be necessary. (C) 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:702 / 708
页数:7
相关论文
共 39 条
  • [1] Population Pharmacokinetic of Vancomycin Administered by Continuous Infusion in Critically Ill Patients
    Ben Romdhane, Haifa
    Woillard, Jean Baptiste
    Ben Fadhel, Najah
    Chadli, Zohra
    Chaabane, Amel
    Boughattas, Naceur
    Ben Fredj, Nadia
    Aouam, Karim
    PHARMACOLOGY, 2024,
  • [2] Continuous infusion of vancomycin is superior to intermittent dosing in critically ill patients
    Potts, S.
    AUSTRALIAN CRITICAL CARE, 2018, 31 (02) : 124 - 124
  • [3] Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy, Andrew A.
    Covajes, Cecilia
    Taccone, Fabio Silvio
    Jacobs, Frederique
    Vincent, Jean-Louis
    Lipman, Jeffrey
    Roberts, Jason A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (06) : 564 - 568
  • [4] Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens
    Roberts, Jason A.
    Taccone, Fabio Silvio
    Udy, Andrew A.
    Vincent, Jean-Louis
    Jacobs, Frederique
    Lipman, Jeffrey
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2704 - 2709
  • [5] Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients
    El-Haffaf, Ibrahim
    Guilhaumou, Romain
    Velly, Lionel
    Marsot, Amelie
    CLINICAL PHARMACOKINETICS, 2022, 61 (06) : 895 - 906
  • [6] Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients
    Ibrahim El-Haffaf
    Romain Guilhaumou
    Lionel Velly
    Amélie Marsot
    Clinical Pharmacokinetics, 2022, 61 : 895 - 906
  • [7] VANCOMYCIN DOSING IN CRITICALLY ILL PATIENTS USING POPULATION PHARMACOKINETICS TO DEVELOP PERSONALISED DOSING REGIMENS TO ACHIEVE TARGET CONCENTRATIONS BY CONTINUOUS INFUSION
    Roberts, Jason A.
    Taccone, Fabio Silvio
    Udy, Andrew
    Vincent, Jean-Louis
    Jacobs, Frederique
    Lipman, Jeffrey
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U24 - U24
  • [8] Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model
    Minichmayr, Iris K.
    Roberts, Jason A.
    Frey, Otto R.
    Roehr, Anka C.
    Kloft, Charlotte
    Brinkmann, Alexander
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (05) : 1330 - 1339
  • [9] Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration
    Sin, Jonathan H.
    Newman, Kelly
    Elshaboury, Ramy H.
    Yeh, D. Dante
    de Moya, Marc A.
    Lin, Hsin
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) : 199 - 203
  • [10] Pharmacokinetic optimization of dosing regimen of aminosides and vancomycin in critically ill patients receiving continuous renal replacement
    Yamamoto, T.
    Yasuno, N.
    Hisaka, A.
    Katada, S.
    Hanafusa, N.
    Suzuki, H.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 511 - 511